Surgical Oncology Research
The Division of Surgical Oncology's active program of clinical and translational research brings the most promising and innovative developments from our laboratories to our patients in need. The Icahn School of Medicine at Mount Sinai is among the institutions receiving the highest amount of funding from the National Institutes of Health for research efforts. Funding for surgical oncology research is provided by the National Cancer Institute, the National Surgical Adjuvant Breast and Bowel Project, and several industry partners.
We are extensively involved in many multi-institutional, international prospective and retrospective studies. Our ongoing research projects include: early cancer detection, tumor markers, cancer genetics, environmental risk factors, minimally invasive surgical techniques, nonsurgical tumor ablation, down staging of advanced cancer to allow for surgical resection, transplantation for tumors, anesthesia for cancer surgery, adjuvant treatment to prevent cancer recurrence, tumor vaccines, gene therapy, and non-chemotherapy treatment of advanced cancer.
View a complete list of all clinical trials available at Mount Sinai Hospital.
Mount Sinai Surgical Associates
Division of Surgical Oncology
1470 Madison Ave, 3rd Fl
New York, NY 10029
The latest Chair's Report elucidates how the Surgical Oncology team is reducing mortality rates for abdominal cancers and researching disparities in treating hepatocellular (liver) cancer. Learn more